Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer
出版年份 2020 全文链接
标题
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer
作者
关键词
-
出版物
ONCOLOGIST
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-09-22
DOI
10.1634/theoncologist.2020-0449
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
- (2019) Jing-ping Li et al. MEDICINE
- Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
- (2019) Neil Vasan et al. SCIENCE
- Implications of ESR1 Mutations in Hormone Receptor-Positive Breast Cancer
- (2018) Tomás Reinert et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
- (2017) M.J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Features of triple-negative breast cancer
- (2016) Magdalena L. Plasilova et al. MEDICINE
- Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients
- (2015) Jiaxin Niu et al. OncoTargets and Therapy
- Multiple hypothesis testing in genomics
- (2014) Jelle J. Goeman et al. STATISTICS IN MEDICINE
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen through Activation of Akt/mTOR Signaling
- (2013) Xi Zhang et al. PLoS One
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- ZNF703is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
- (2011) Daniel G. Holland et al. EMBO Molecular Medicine
- Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer
- (2008) Kirsimari Aaltonen et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now